Ufp Technologies (UFPT) Cash from Investing Activities (2010 - 2026)
Ufp Technologies (UFPT) posted Cash from Investing Activities of -$1.7 million for Q1 2026, up 56.22% on a QoQ basis from -$3.9 million in Q4 2025, and up 40.08% year-over-year from -$1.2 million in Q1 2025.
Ufp Technologies (UFPT) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Ufp Technologies' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
- Quarterly Cash from Investing Activities rose 40.08% year-over-year to -$1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$26.5 million (up 87.47% YoY) and the FY2025 annual result came in at -$27.6 million, up 86.87% from the prior year.
- Cash from Investing Activities was -$1.7 million for Q1 2026 at Ufp Technologies, up from -$3.9 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $33.4 million in Q3 2022 and bottomed at -$197.2 million in Q3 2024.
- A 5-year average of -$14.6 million and a median of -$3.0 million in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 3560.93% — and 2024, when it tumbled 6979.61%.
- Ufp Technologies' Cash from Investing Activities stood at -$3.0 million in 2022, then advanced by 7.02% to -$2.8 million in 2023, then slumped by 40.93% to -$3.9 million in 2024, then gained by 0.72% to -$3.9 million in 2025, then soared by 56.22% to -$1.7 million in 2026.
- Business Quant data shows UFPT's Cash from Investing Activities at -$1.7 million in Q1 2026, -$3.9 million in Q4 2025, and -$15.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Ufp Technologies | 1.90 Bn | 1.88 Bn | 44.36 Mn | -1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.69 Mn |
| Mar 31, 2026 | -1.69 Mn |
| Dec 31, 2025 | -3.86 Mn |
| Dec 31, 2025 | -3.86 Mn |
| Sep 30, 2025 | -15.27 Mn |
| Sep 30, 2025 | -15.27 Mn |
| Jun 30, 2025 | -5.65 Mn |
| Jun 30, 2025 | -5.65 Mn |
| Mar 31, 2025 | -2.82 Mn |
| Mar 31, 2025 | -2.82 Mn |
| Dec 31, 2024 | -3.88 Mn |
| Dec 31, 2024 | -3.88 Mn |
| Sep 30, 2024 | -197.17 Mn |
| Sep 30, 2024 | -197.17 Mn |
| Jun 30, 2024 | -7.38 Mn |
| Jun 30, 2024 | -7.38 Mn |
| Mar 31, 2024 | -1.73 Mn |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | -2.76 Mn |
| Dec 31, 2023 | -2.76 Mn |